Study to Assess the Efficacy, Safety and Pharmacokinetics of Orally Administered Tebipenem Pivoxil Hydrobromide (SPR994) Compared to Intravenous Ertapenem in Participants With Complicated Urinary Tract Infection (cUTI) or Acute Pyelonephritis (AP)

NCT03788967 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1372

Enrollment

INDUSTRY

Sponsor class

Conditions

Complicated Urinary Tract Infection
Acute Pyelonephritis

Interventions

DRUG: TBPM-PI-HBr
DRUG: Ertapenem
DRUG: Dummy Infusion
DRUG: Dummy tablets

Sponsor

Spero Therapeutics